J&J hit with suit over Neutrogena products

Canadian firm alleges infringement of patent directed to cosmetic and pharmaceutical formulations | Pharma giant declined a licensing agreement.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Eye care company settles with J&J Surgical Vision for $199m

13 February 2023 J&J had accused defendant of infringing patents related to cataract surgery | Company also complained its copyright-protected computer programs had been ripped off, alleging “piracy of a nearly unfathomable scale”.

Americas

J&J accuses ex-employees of stealing trade secrets

15 December 2022 Lawsuit alleges former employees stole a “treasure trove” of confidential information from three J&J units | Complaint says defendant engaged in a systematic process of hiring Auris staff.

Big Pharma

J&J settles Amgen clash over blockbuster psoriasis drug

25 May 2023 Amgen can market biosimilar version of Stelara from January 2025 | J&J had alleged infringement of two Stelara patents.